Dieter Riemann, PhD, is affiliated with the Department of Psychiatry and Psychotherapy and the Center for Basics in NeuroModulation at the University of Freiburg, Germany. Riemann has published research on topics including neurology and suicide, focusing on subjects such as the potential suicide risk associated with daridorexant, the impact of sleep-related complaints on depressive symptoms in restless legs syndrome, and the use of doxepin for primary insomnia. Collaborators frequently include Mathias Berger, Ulrich Voderholzer, Andrea Rodenbeck, Angelo Gemignani, and Eckart Rüther.
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
